Regioselective addition of aniline to 8H-pyrido [2,3,4-mn] acridinone: Structure determination of the reaction product

Magnetic Resonance in Chemistry

Volumn 35, Issue 10, 1997, Pages 697-700

  Fixler, N ^a   Demeunynck, M ^a   Brochier, M C ^a   Garcia, J ^a   Lhomme, J ^a  

^a CNRS   (France)

Author keywords

2D NMR; HMBC; HMQC; Pyrido acridine H D exchange

Indexed keywords

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REGIOSELECTIVITY;

2-D NMR; H-D EXCHANGE; HMBC; HMQC; NMR STUDIES; NMR TECHNIQUES; PYRIDO-ACRIDINE H-D EXCHANGE; REGIO-SELECTIVE; REGIOSELECTIVE ADDITION; STRUCTURE DETERMINATION;

ANILINE;

EID: 0031520278     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-458x(199711)35:10<697::aid-omr156>3.3.co;2-d     Document Type: Article

References (18)

1. For a review, see T. F. Molinski, Chem. Rev. 93, 1825 (1993).
2. I. Spector, N. R. Shochet, Y. Kashman, A. Rudi and G. Gellerman, US Pat. 5 432 172 (1995); I. Spector, N. R. Shochet, Y. Kashman and A. Rudi, US Pat. 5 278 168 (1994).
3. I. Spector, N. R. Shochet, Y. Kashman, A. Rudi and G. Gellerman, US Pat. 5 432 172 (1995); I. Spector, N. R. Shochet, Y. Kashman and A. Rudi, US Pat. 5 278 168 (1994).
4. For examples, see G. Simino, A. Crispino, S. De Rosa, S. de Stefano, M. Gavagnin and G. Sodano, Tetrahedron 43, 4023 (1987); F. S. de Guzman and F. J. Schmitz, Tetrahedron Lett. 30, 1069 (1989).
5. For examples, see G. Simino, A. Crispino, S. De Rosa, S. de Stefano, M. Gavagnin and G. Sodano, Tetrahedron 43, 4023 (1987); F. S. de Guzman and F. J. Schmitz, Tetrahedron Lett. 30, 1069 (1989).
6. J. Kim, E. O. Pordesimo, S. I. Toth and F. J. Schmitz, J. Nat. Prod. 56, 1813 (1993); F. J. Schmitz, S. K. Agarwal, S. P. Gunasekera, P. G. Schmidt and J. N. Shoolery, J. Am. Chem. Soc. 105, 4835 (1983); N. Bontemps, I. Bonnard, B. Banaigs, G. Combaut and C. Francisco, Tetrahedron Lett. 35, 7023 (1994).
7. J. Kim, E. O. Pordesimo, S. I. Toth and F. J. Schmitz, J. Nat. Prod. 56, 1813 (1993); F. J. Schmitz, S. K. Agarwal, S. P. Gunasekera, P. G. Schmidt and J. N. Shoolery, J. Am. Chem. Soc. 105, 4835 (1983); N. Bontemps, I. Bonnard, B. Banaigs, G. Combaut and C. Francisco, Tetrahedron Lett. 35, 7023 (1994).
8. J. Kim, E. O. Pordesimo, S. I. Toth and F. J. Schmitz, J. Nat. Prod. 56, 1813 (1993); F. J. Schmitz, S. K. Agarwal, S. P. Gunasekera, P. G. Schmidt and J. N. Shoolery, J. Am. Chem. Soc. 105, 4835 (1983); N. Bontemps, I. Bonnard, B. Banaigs, G. Combaut and C. Francisco, Tetrahedron Lett. 35, 7023 (1994).
9. J. Lhomme, D. C. H. Bigg, A. Duflos, B. Bonnaud, M. Demeunynck, C. Etievant and R. Kiss Pierre, Fabre Médicament, PCT Int. Pat. Appl. WO 94 25 439 (1994); A. Duflos, D. C. H. Bigg, J. Lhomme, N. Fixler, C. Etievant and M. Demeunynck, Pierre Fabre Médicament, Fr. Pat. 2 712 290 (1995); A. Wardani, J. Lhomme, D. C. H. Bigg and H. Salez, Pierre Fabre Médicament, PCT Int. Pat. Appl. WO 91 07 403 (1991); A Wardani and J. Lhomme, Tetrahedron Lett. 34, 6411 (1993).
10. J. Lhomme, D. C. H. Bigg, A. Duflos, B. Bonnaud, M. Demeunynck, C. Etievant and R. Kiss Pierre, Fabre Médicament, PCT Int. Pat. Appl. WO 94 25 439 (1994); A. Duflos, D. C. H. Bigg, J. Lhomme, N. Fixler, C. Etievant and M. Demeunynck, Pierre Fabre Médicament, Fr. Pat. 2 712 290 (1995); A. Wardani, J. Lhomme, D. C. H. Bigg and H. Salez, Pierre Fabre Médicament, PCT Int. Pat. Appl. WO 91 07 403 (1991); A Wardani and J. Lhomme, Tetrahedron Lett. 34, 6411 (1993).
11. J. Lhomme, D. C. H. Bigg, A. Duflos, B. Bonnaud, M. Demeunynck, C. Etievant and R. Kiss Pierre, Fabre Médicament, PCT Int. Pat. Appl. WO 94 25 439 (1994); A. Duflos, D. C. H. Bigg, J. Lhomme, N. Fixler, C. Etievant and M. Demeunynck, Pierre Fabre Médicament, Fr. Pat. 2 712 290 (1995); A. Wardani, J. Lhomme, D. C. H. Bigg and H. Salez, Pierre Fabre Médicament, PCT Int. Pat. Appl. WO 91 07 403 (1991); A Wardani and J. Lhomme, Tetrahedron Lett. 34, 6411 (1993).
12. J. Lhomme, D. C. H. Bigg, A. Duflos, B. Bonnaud, M. Demeunynck, C. Etievant and R. Kiss Pierre, Fabre Médicament, PCT Int. Pat. Appl. WO 94 25 439 (1994); A. Duflos, D. C. H. Bigg, J. Lhomme, N. Fixler, C. Etievant and M. Demeunynck, Pierre Fabre Médicament, Fr. Pat. 2 712 290 (1995); A. Wardani, J. Lhomme, D. C. H. Bigg and H. Salez, Pierre Fabre Médicament, PCT Int. Pat. Appl. WO 91 07 403 (1991); A Wardani and J. Lhomme, Tetrahedron Lett. 34, 6411 (1993).
13. N. Fixler, M. Demeunynck and J. Lhomme, Synth. Commun. 27, 2311 (1997).
14. B. Fugman. B. Steffan and W. Steglich, Tetrahedron Lett. 25, 3575 (1984); C. S. Hilger, B. Fugman and W. Steglich, Tetrahedron Lett. 26, 5975 (1985).
15. B. Fugman. B. Steffan and W. Steglich, Tetrahedron Lett. 25, 3575 (1984); C. S. Hilger, B. Fugman and W. Steglich, Tetrahedron Lett. 26, 5975 (1985).
16. D. M. Doddrell, D. T. Pegg and M. R. Bendall, J. Magn. Reson. 48, 323 (1982).
17. A. Bax and S. Subramanian, J. Magn. Reson. 67, 565 (1986).
18. A. Bax and M. F. Summers, J. Am. Chem. Soc. 108, 2093 (1986).